GOLDEN GLOBAL CORP

Golden Global Corp Stock

Stocks

GLDG

US3810573069

Pharmaceuticals

Delayed NYSE			5-day change	1st Jan Change
- ^USD	-.--%		-0.41%	-

01-26	Top Midday Gainers	MT
01-26	GoldMining Reports Gold Mineralization at Depth in Brazil Drilling Project	MT

Latest news: Golden Global Corp

01-26	Top Midday Gainers	MT
01-26	GoldMining Reports Gold Mineralization at Depth in Brazil Drilling Project	MT
11-12	GoldMining Granted Renewal of Brazilian Exploration Claim	MT
23-09-27	HC Wainwright Adjusts GoldMining Price Target to $4.50 From $5.25, Maintains Buy Rating	MT
23-07-25	HC Wainwright Adjusts Price Target on GoldMining to $5.25 From $5, Maintains Buy Rating	MT
23-07-13	Nevgold Issues GoldMining 4.11-Million Shares Under Option Agreement to Acquire the Nutmeg Mountain Gold Project	MT
23-07-10	Gold Closes Lower But Rises Off Early Losses as the Dollar Drops	MT
23-07-10	Gold Moves Lower Early as the Dollar Strengthens Ahead of This Week's US Inflation Data	MT
23-05-19	HC Wainwright Adjusts Price Target on GoldMining to $5 From $5.25, Keeps Buy Rating	MT
23-04-20	GoldMining Subsidiary Prices $20 Million Initial Public Offering	MT
22-09-13	GoldMining Sees Extended Mineralization at the La Garrucha Target in Colombia	MT
22-06-15	HC Wainwright Trims GoldMining's Price Target to $6.25 From $6.50, Maintains Buy Rating	MT
21-12-13	GoldMining Launches Equity Offering Program	MT

Analysts' recommendations: Golden Global Corp

23-09-27	HC Wainwright Adjusts GoldMining Price Target to $4.50 From $5.25, Maintains Buy Rating	MT
23-07-25	HC Wainwright Adjusts Price Target on GoldMining to $5.25 From $5, Maintains Buy Rating	MT
23-05-19	HC Wainwright Adjusts Price Target on GoldMining to $5 From $5.25, Keeps Buy Rating	MT
22-06-15	HC Wainwright Trims GoldMining's Price Target to $6.25 From $6.50, Maintains Buy Rating	MT
21-08-30	Golden Global : HC Wainwright Adjusts GoldMining's Price Target to $6 from $5.75, Keeps Buy Rating	MT

More recommendations

Press Releases: Golden Global Corp

09-17	Nevada's Oxide Gold Districts Are Being Redrilled for a Second Metal	AQ
07-22	GoldMining Files PEA Technical Report for its São Jorge Project, Brazil	AQ
06-25	GoldMining Issues Mid-Year 2026 Shareholder Update	AQ
06-11	GoldMining Announces Positive PEA Highlighting $532 Million After-Tax NPV and 42% IRR at its São Jorge Project, Brazil	AQ
06-09	This Gold Story Is Starting to Look Bigger Than a Few High-Grade Samples	AQ

More press releases

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	GOLDEN GLOBAL CORP	-.--%	-0.41%	-	-	0
	ELI LILLY AND COMPANY	+1.28%	+2.62%	+51.61%	+100.19%	1,014B
	JOHNSON & JOHNSON	+1.10%	+1.45%	+52.49%	+67.37%	644B
	ABBVIE INC.	+0.58%	+3.54%	+19.57%	+73.56%	464B
	ROCHE HOLDING AG	-0.36%	+4.54%	+38.71%	+38.21%	354B
	NOVARTIS AG	+1.52%	+3.46%	+20.13%	+25.75%	265B
	ASTRAZENECA PLC	+2.41%	+5.70%	+9.06%	+13.60%	253B
	AMGEN INC.	+0.91%	-0.70%	+38.25%	+45.67%	203B
	NOVO NORDISK A/S	+2.48%	-2.43%	-24.40%	-58.09%	186B
	GILEAD SCIENCES, INC.	+2.17%	+4.20%	+34.41%	+99.41%	183B
	Average	+0.83%	+1.98%	+26.65%	+45.07%	396.31B
	Weighted average by Cap.	+0.20%	+2.35%	+35.35%	+61.57%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
GLDG Stock

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!